Yüklüyor......
T-cell Immunotherapies and the Role of Nonclinical Assessment: The Balance between Efficacy and Pathology
Gene-engineered T-cell therapies have the potential to revolutionize the treatment of cancer. These therapies have shown exceptional clinical efficacy specifically in the field of B-cell malignancies and the first products (Kymriah™ and Yescarta™) have recently been approved in the United States for...
Kaydedildi:
| Yayımlandı: | Toxicol Pathol |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5843031/ https://ncbi.nlm.nih.gov/pubmed/29471776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0192623317752101 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|